- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Automatic Translation feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Protection of a New Heptapeptide from <i>Carapax trionycis</i> against Carbon Tetrachloride-Induced Acute Liver Injury in Mice
-
- Wang Penglong
- School of Chinese Pharmacy, Beijing University of Chinese Medicine
-
- Zhang Yuzhong
- Department of Pathology, Beijing University of Chinese Medicine
-
- An Yawen
- School of Chinese Pharmacy, Beijing University of Chinese Medicine Institute of Materia Medica, Chinese Academy of Medical Sciences Peking Union Medical College
-
- Xu Kuo
- School of Chinese Pharmacy, Beijing University of Chinese Medicine
-
- Xu Xin
- School of Chinese Pharmacy, Beijing University of Chinese Medicine
-
- Fu Chao
- School of Chinese Pharmacy, Beijing University of Chinese Medicine
-
- Lin Jinxuan
- Department of Pathology, Beijing University of Chinese Medicine
-
- Xu Shixun
- School of Chinese Pharmacy, Beijing University of Chinese Medicine
-
- Li Qiang
- School of Chinese Pharmacy, Beijing University of Chinese Medicine
-
- Lei Haimin
- School of Chinese Pharmacy, Beijing University of Chinese Medicine
Bibliographic Information
- Other Title
-
- Protection of a New Heptapeptide from Carapax trionycis against Carbon Tetrachloride-Induced Acute Liver Injury in Mice
Search this article
Description
A new heptapeptide GAGPHGG (OC1) was isolated from Carapax trionycis which was a traditional Chinese medicine (TCM) used for treatment of hepatic diseases. The structure of OC1 was characterized by MS, NMR techniques, together with amino acid sequence analysis. The hepatoprotective activity of OC1 was evaluated in vivo using the CCl4-induced acute liver injury model. Combining the pathological examination and the biochemical assays, OC1 (0.34 mg/kg, hypodermic injection) displayed better hepatoprotective effect than bifendate (100 mg/kg, intragastric administration) against the acute liver injury induced by carbon tetrachloride (CCl4) in mice. Compared with the model group, OC1 could significantly suppress the increase of serum level of aminotransferase (alanine transaminase (ALT) and aspartate aminotransferase (AST)), decrease the formation of malondialdehyde (MDA) and elevate the activity of glutathione peroxidase (GSH-Px) in liver (p<0.01). And the acute toxic test showed that median lethal dose (LD50) of OC1 exceeded 6.8 mg/kg, via hypodermic injection in mice.
Journal
-
- Chemical and Pharmaceutical Bulletin
-
Chemical and Pharmaceutical Bulletin 61 (11), 1130-1135, 2013
The Pharmaceutical Society of Japan
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282679155728256
-
- NII Article ID
- 130003381778
-
- NII Book ID
- AA00602100
-
- COI
- 1:STN:280:DC%2BC2c7ivFyjtQ%3D%3D
-
- ISSN
- 13475223
- 00092363
-
- NDL BIB ID
- 024957143
-
- PubMed
- 24189300
-
- Text Lang
- en
-
- Article Type
- journal article
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- PubMed
- CiNii Articles
-
- Abstract License Flag
- Disallowed